OZAM INJECTION is a monobactam antibiotic primarily active against aerobic Gram-negative bacteria.
How it works:
Aztreonam binds to penicillin-binding proteins and inhibits bacterial cell wall synthesis, leading to cell lysis and death. It is resistant to many beta-lactamases, making it effective against resistant strains.
Recommended for:
Clinical evidence:
Aztreonam has been extensively studied and widely used in the management of severe Gram-negative infections. Clinical trials confirm its efficacy in respiratory, urinary, and systemic infections. It is generally well tolerated and considered a valuable alternative in patients with hypersensitivity to other beta-lactam antibiotics.
Indicated for infections caused by susceptible Gram-negative microorganisms, including respiratory tract, urinary tract, intra-abdominal, skin, and soft tissue infections. It acts by disrupting bacterial cell wall synthesis.
Administered intravenously or intramuscularly under medical supervision. Dosage and treatment duration depend on the severity of infection and patient condition. Therapy should be carried out as prescribed by a healthcare professional.
Contraindications
Side Effects
